A carregar...
MEK Inhibition in Non-Small Cell Lung Cancer
KRAS mutations are the most common mutations in non-small cell lung cancer (NSCLC) with adenocarcinoma histology. KRAS mutations result in the activation of the RAF-MEK-ERK pathway, and agents that target RAF-MEK-ERK pathways have been investigated in KRAS mutant NSCLC. The two agents furthest in de...
Na minha lista:
| Publicado no: | Lung Cancer |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4406476/ https://ncbi.nlm.nih.gov/pubmed/25257766 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2014.09.005 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|